{
  "docId": "019dd923-622c-750b-8b9a-40e2965928db",
  "docSlug": "e5bffbaac707",
  "documentTitle": "TransMedics (TMDX)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-01-10 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 21,
  "pageCount": 342,
  "prevPage": 20,
  "nextPage": 22,
  "slideType": "villain_critique",
  "function": "expose_contradiction",
  "density": "balanced",
  "nDataPoints": 3,
  "notes": "The slide uses a combination of narrative analysis and direct testimonial quotes to build a bearish case against the company.",
  "elementsJson": [
    "paragraph",
    "quote_block"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-40e2965928db/21",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-40e2965928db",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-40e2965928db.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-40e2965928db#slide-21",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "With Vanderbilt gone and UCSF/MGH next – three of the top centers in the US and globally, by case volumes and influence – it is game, set, match.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-5372-7340-8f9a-20ab3c3fd0ae",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.62,
        "w": 0.86,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "paragraph",
      "text": "UCSF, Massachusetts General, UCSD, and Cedars-Sinai are just a partial set of the large, current customers we spoke with who are on the verge of fleeing - all of it, we believe, yet to reflect in the coming quarters.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "96a7b3db-139e-4944-acf2-b7c191dcfb3a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.86,
        "x": 0.07,
        "y": 0.72
      },
      "kind": "quote",
      "text": "Yeah, that's what's going to happen. It's not new technology, I mean, it's been around for a while. Like NRP, I think it's going to be a huge game-changer.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "50231914-ec5f-48eb-b5b6-ca23ac64d1e5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "Like NRP, I think it’s going to be a huge game-changer. And you see some of this initial data that’s coming out even from Europe, and you’re like, “Why are we not doing this?” NRP is going to probably be standard. There’s going to be no real utility in using an OCS in comparison to other cheaper, more widely available, and more preferable from a business-to-business standpoint—it’s a no-brainer. [...] For livers, probably in the next six months [...] I think we’ll probably stop using it. It’s gotten to that point [...] the market has shifted...the clinicians who have been very, very concerned about the poor business practices and misalignment of incentives with TransMedics, that there are now going to be other technologies...it’s very promising that there’s going to be a different option, not only from the actual product standpoint but just from a business standpoint, I would switch right away. — Veteran transplant administrator/executive in a senior role at Massachusetts General Hospital",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-5372-7340-8f9a-26d2e41ac42b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.3,
        "x": 0.07,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f111030d-fbed-446c-8381-a3465c4a43c1",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "antagonist-introduction",
      "slug": null,
      "matchId": "2dfee5ea-b5b1-4e66-9de4-3b1eef66c085",
      "evidence": "The slide frames TransMedics as the antagonist in a narrative of customer dissatisfaction and business failure.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 30,
      "from": 12,
      "beatId": "072007ec-5fd3-4416-b852-0e181a364efd",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Exposure of Contradictions",
      "beatSlug": null,
      "evidence": "The section highlights contradictions in TransMedics Group Inc.'s statements and actions.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}